Struggling with Increased Sensitivity: PSMA PET/CT - Michael Hofman

Presentation from the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting.   (Length of video ~ 23 minutes)

Michael Hofman discusses PSMA as the new “gold standard” and how it is significantly superior to existing imaging modalities through case studies from the Peter MacCallum Cancer Centre and a review of abstracts.

Related content:
Systemic Radioligand Therapy with (177)Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer.

68Ga-PSMA has high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment.

AUA 2017: 11C-Choline versus 68ga-PSMA PET/CT scan for the detection of nodal recurrence from prostate cancer: results from a large, multi-institutional salvage lymph node dissection series

Michael Hofman
Associate Professor
Molecular Imaging,Centre for Cancer Imaging
Peter MacCallum Cancer Centre/The University of Melbourne 


Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.